Many of the side effects of tamoxifen may be worth risking if you have cancer. However the risk/benefit equation changes considerably if you are healthy and offered the drug as a just in case mea ...
Yet another clinical trial of tamoxifen can’t decide if the drug is worth taking.
Originally hailed as a major contribution to breast cancer prevention, tamoxifen has had a bumpy ride
The drug company giveth, and it taketh away, too. The thought came to mind after we looked at the success of the drug tamoxifen in fighting - and preventing - breast cancer. Unfortunately it's likely to give you endometrial cancer instead. But it...
If you worry that drugs cause enough serious adverse reactions and side-effects even after passing through a supposed draconian approval process, you’ll be even more concerned about a subtle lobbying that could lead to a relaxation of the licensing...
A second major cancer study in the US has been discredited after data had been falsified. The news follows the revelation just a month earlier that the biggest survey on breast cancer in North Ame ...
Breast cancer patients have nothing to gain from taking tamoxifen for longer than five years, according to a new study. ...
Tamoxifen, the breast cancer drug currently in the middle of a controversy over its safety, is to carry a stronger warning in the US. New labelling on the bottle is to point out the increased risk ...
The breast cancer drug tamoxifen may cause birth defects. ...
Hopes of finding healthy women to test tamoxifen, the breast cancer drug, have taken a further blow following a new study from Scotland. ...
New evidence from the Netherlands shows that long term tamoxifen use increases the risk of endometrial cancers with a poor prognosis. ...